Publication

Maternal Malaria Induces a Procoagulant and Antifibrinolytic State That Is Embryotoxic but Responsive to Anticoagulant Therapy

Downloadable Content

Persistent URL
Last modified
  • 02/25/2025
Type of Material
Authors
    John W. Avery, University of GeorgiaGeoffrey M. Smith, University of GeorgiaSimon O. Owino, University of GeorgiaDemba Sarr, University of GeorgiaTamas Nagy, University of GeorgiaStephen Mwalimu, University of GeorgiaJames Matthias, University of GeorgiaLauren F. Kelly, University of GeorgiaJayakumar S. Poovassery, University of GeorgiaJoab D. Middii, University of GeorgiaCarlos Abramowsky, Emory UniversityJulie M. Moore, University of Georgia
Language
  • English
Date
  • 2012-02-07
Publisher
  • Public Library of Science
Publication Version
Copyright Statement
  • © 2012 Avery et al.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1932-6203
Volume
  • 7
Issue
  • 2
Start Page
  • e31090
End Page
  • e31090
Grant/Funding Information
  • This work was supported by the National Institutes of Health grants R01 AI050240 and R01 HD046860 to JMM.
Supplemental Material (URL)
Abstract
  • Low birth weight and fetal loss are commonly attributed to malaria in endemic areas, but the cellular and molecular mechanisms that underlie these poor birth outcomes are incompletely understood. Increasing evidence suggests that dysregulated hemostasis is important in malaria pathogenesis, but its role in placental malaria (PM), characterized by intervillous sequestration of Plasmodium falciparum, proinflammatory responses, and excessive fibrin deposition is not known. To address this question, markers of coagulation and fibrinolysis were assessed in placentae from malaria-exposed primigravid women. PM was associated with significantly elevated placental monocyte and proinflammatory marker levels, enhanced perivillous fibrin deposition, and increased markers of activated coagulation and suppressed fibrinolysis in placental plasma. Submicroscopic PM was not proinflammatory but tended to be procoagulant and antifibrinolytic. Birth weight trended downward in association with placental parasitemia and high fibrin score. To directly assess the importance of coagulation in malaria-induced compromise of pregnancy, Plasmodium chabaudi AS-infected pregnant C57BL/6 mice were treated with the anticoagulant, low molecular weight heparin. Treatment rescued pregnancy at midgestation, with substantially decreased rates of active abortion and reduced placental and embryonic hemorrhage and necrosis relative to untreated animals. Together, the results suggest that dysregulated hemostasis may represent a novel therapeutic target in malaria-compromised pregnancies.
Author Notes
Keywords
Research Categories
  • Health Sciences, Pathology
  • Biology, Microbiology
  • Health Sciences, Obstetrics and Gynecology

Tools

Relations

In Collection:

Items